Here’s how a drug gets from an idea into patients’ hands – and why Australians sometimes wait longer to access a new drug ...

Australia's drug approval system is under fire, with critics in the United States claiming it is too slow to approve life-saving medicines.Author ...

Healthcare analyst Ellen Andrews, Ph. D, highlights a first-in-the-nation bill that the state passed this year in an effort to control generic drug prices.

Employers, some lawmakers and others have criticized pharmacy benefit managers (PBMs), especially the "big three," for having ...

State legislatures, including Oregon, have tried to level the playing field for pharmacies. Mayo said reform efforts in Oregon have focused on requiring pharmacy benefit managers to pay dispensing ...

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug ...

Since 2005, the cost of health care has increased an average of 6% each year, and the burden falls on both employers and ...

Donald Trump has 'sparked alarm' by threatening a 50% tariff on non-US copper and a 200% tariff on imported pharmaceuticals.

In other countries, the government negotiates with pharmaceutical companies directly to set a single market price. In the U.S ...

Patient-reported outcomes could have a prognostic and predictive impact on care for multiple myeloma.A retrospective analysis ...

American entrepreneur and investor Mark Cuban tells us why he and his partners launched the Mark Cuban Cost Plus Drug Company (MCCPDC), a public-benefit corporation and online pharmacy that ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...